Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2024-06-11FDA Approved: HYDROCORTISONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a Supplemental Application for HYDROCORTISONE from Aurobindo Pharma Limited, typically indicating a label change for this gener…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis [Phase 2]
Phase 2 proof-of-concept trial evaluating VLY-686 for treatment-resistant pruritus associated with atopic dermatitis; results have been post…
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3) [Phase 3]
Phase 3 trial results for ruxolitinib cream in pediatric atopic dermatitis have been posted.
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis
This clinical trial investigates the analytical validation of a wrist-worn device for measuring nocturnal scratching in individuals with ato…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis [NA]
This clinical trial update describes using the SpiderMass system for in vivo skin analysis across five chronic inflammatory dermatoses and n…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]
Pfizer completed a Phase 1 study evaluating safety and tolerability of PF-07242813 in healthy participants and in individuals with atopic de…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating the efficacy and safety of LEO 152020 tablets in adults with moderate to severe atopic dermatitis; results have bee…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children [Phase 4]
A Phase 4 clinical trial evaluating non-specific effects of a modified measles vaccination schedule to prevent allergy and unrelated infecti…
-
FDA approval · 2024-05-29FDA Approved: HALCINONIDE TOPICAL SOLUTION — Original Application (INA Pharmaceutics Inc)
FDA approved the Original Application for halcinonide topical solution from INA Pharmaceutics Inc, a generic version.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Infant Restore: Efficacy of Microbiome Analysis and Education [NA]
ClinicalTrials.gov entry for the Infant Restore study, evaluating microbiome analysis and education for infants with eczema, currently activ…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema. [NA]
A completed clinical trial evaluated Adex Gel for the treatment of atopic dermatitis (eczema) sponsored by Dermal Laboratories Ltd.
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) [Phase 3]
Phase 3 trial (EPIONE2) evaluating tradipitant vs placebo for atopic dermatitis was terminated with results posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis [NA]
This document notes the completion of a clinical trial evaluating a mobile health app for managing pediatric atopic dermatitis. The update d…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE) [Phase 3]
Phase 3 EPIONE trial evaluating tradipitant versus placebo in atopic dermatitis has completed and posted results on 2024-05-13.
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis [Phase 1]
A phase 1 study of LY3844583 in healthy participants and individuals with atopic dermatitis was terminated; the document does not report stu…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis. [Phase 2]
Phase 2 trial evaluating CMK389 for moderate to severe Atopic Dermatitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2a trial is evaluating the efficacy and safety of OpSCF in adults with moderate to severe atopic dermatitis; current trial status is…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Skin Pathology Assessment With Optical Technologies
This document reports the completion of a clinical trial evaluating optical technologies for assessing skin pathology in patients with atopi…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Mind and Skin - the Neurocutaneous Axis in Atopic Eczema
A clinical trial from King's College London investigating the neurocutaneous axis in atopic dermatitis, currently in the recruiting phase.
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China [Phase 2]
A Phase 2 trial evaluating CBP-201 for moderate-to-severe atopic dermatitis in China has completed and posted results.
-
FDA approval · 2024-04-30FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (The J. Molner Company LLC)
FDA approves a supplemental application for hydrocortisone butyrate (ANDA 209556) by The J. Molner Company LLC. The approval updates the pro…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis [NA]
A clinical trial is currently recruiting to investigate the effect of biodiversity exposure via sand play on Atopic Dermatitis.
-
FDA approval · 2024-04-26FDA Approved: RINVOQ — Original Application (AbbVie Inc.)
The FDA approved Rinvoq (upadacitinib) from AbbVie under an Original Application NDA, granting the drug its initial US marketing authorizati…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]
ASLAN Pharmaceuticals reports that the Phase 2b trial of ASLAN004 for adults with moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase III study evaluating the efficacy and safety of AK120 in adults with moderate to severe atopic dermatitis is currently recruiting.